Evidence map›Paper›PMID 33841162›Full record

ArticleFrontiers in pharmacology2021

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism.

Yuling Tong, Liping Liu, Ruilin Wang, Tao Yang, Jianxia Wen, Shizhang Wei, Manyi Jing, Wenjun Zou, Yanling Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current pharmaceutical design · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Berberine Alleviates 1-Methyl-3-Nitro-1-Nitrosoguanidine- Induced Chronic Atrophic Gastritis in Rats.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuling TongCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Liping LiuIntegrative Medical Center, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Ruilin WangIntegrative Medical Center, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Tao YangDepartment of Pharmacy, Chinese PLA General Hospital, Beijing, China.
Jianxia WenCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Shizhang WeiCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Manyi JingDepartment of Pharmacy, Chinese PLA General Hospital, Beijing, China.
Wenjun ZouCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yanling ZhaoDepartment of Pharmacy, Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the therapeutic effect of berberine (BBR) on MNNG-induced chronic atrophic gastritis (CAG) and the possible mechanism of BBR through TGF-β1/PI3K signal pathway. GES-1 were pretreated with MNNG for 2 h before BBR treatment in all procedures. Cell viability was quantified by cell counting kit-8, and GES-1 morphology and proliferation were detected by high content screening (HCS) assay. The rat model of CAG was established by MNNG, and the therapeutic effect of BBR on stomach histopathology and serum supernatant were analyzed

Indexed as

berberinechronic atrophic gastritisMNNGPI3K/AKT/mTORTGF-β1

Identifiers

PMID33841162
PMCPMC8026873
OpenAlexW3151115053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.